# Document 2: Digital Health AI Capabilities Library
## Comprehensive Capability Definitions for Dynamic Loading

---

## ðŸ“š Capability Library Structure

### Capability Definition Template
```json
{
  "capability_id": "CAP-[DOMAIN]-[NUMBER]",
  "title": "Capability Name",
  "description": "Detailed description of what this capability enables",
  "methodology": "Step-by-step process for executing this capability",
  "required_knowledge": ["List of knowledge domains needed"],
  "tools_required": ["External tools or databases needed"],
  "output_format": "Expected format of results",
  "quality_metrics": {
    "accuracy_target": "95%",
    "time_target": "5 minutes",
    "compliance_requirements": ["FDA", "ISO", "etc"]
  },
  "examples": ["Example use cases"],
  "limitations": ["Known limitations or constraints"]
}
```

---

## ðŸ›ï¸ FDA REGULATORY CAPABILITIES

### CAP-FDA-001: FDA Pathway Analysis
```json
{
  "capability_id": "CAP-FDA-001",
  "title": "FDA Pathway Analysis",
  "description": "Comprehensive analysis of FDA regulatory pathways for medical devices, including 510(k), De Novo, PMA, HDE, and 513(g) determinations",
  "methodology": {
    "step_1": "Device Classification Determination",
    "process": [
      "1. Analyze device intended use and indications",
      "2. Review 21 CFR Parts 862-892 for classification regulations",
      "3. Search FDA Product Classification Database",
      "4. Assess risk profile (Class I, II, or III)",
      "5. Identify applicable product codes"
    ],
    "step_2": "Pathway Options Assessment",
    "process": [
      "1. Evaluate 510(k) eligibility with predicate search",
      "2. Assess De Novo criteria if no valid predicate",
      "3. Determine if PMA required for Class III",
      "4. Consider special pathways (HDE, BDD, STeP)",
      "5. Calculate probability of success for each pathway"
    ],
    "step_3": "Evidence Requirements Mapping",
    "process": [
      "1. Identify clinical data requirements",
      "2. Determine bench testing needs",
      "3. Assess software validation requirements",
      "4. Map biocompatibility testing",
      "5. Define sterilization validation if applicable"
    ]
  },
  "required_knowledge": [
    "21 CFR Part 807 (510(k) requirements)",
    "21 CFR Part 814 (PMA requirements)",
    "21 CFR Part 860 (De Novo classification)",
    "FDA guidance documents by device type",
    "CDRH Learn modules"
  ],
  "tools_required": [
    "FDA Product Classification Database",
    "510(k) Database for predicate search",
    "FDA Guidance Document Database",
    "CDRH Standards Recognition Database"
  ],
  "output_format": {
    "recommended_pathway": "Primary recommendation with confidence level",
    "alternative_pathways": "Backup options with pros/cons",
    "evidence_requirements": "Detailed testing matrix",
    "timeline": "Gantt chart with milestones",
    "cost_estimate": "Budget range for pathway",
    "risk_assessment": "Key risks and mitigation strategies"
  },
  "quality_metrics": {
    "accuracy_target": "98%",
    "time_target": "30 minutes",
    "compliance_requirements": ["FDA QSR", "21 CFR Part 820"]
  },
  "examples": [
    "AI-powered diagnostic imaging device â†’ 510(k) with special controls",
    "Novel implantable sensor â†’ De Novo classification",
    "High-risk cardiac device â†’ PMA pathway"
  ],
  "limitations": [
    "Combination products may require additional analysis",
    "Novel AI/ML may need pre-submission discussion",
    "International requirements not included"
  ]
}
```

### CAP-FDA-002: 510(k) Submission Support
```json
{
  "capability_id": "CAP-FDA-002",
  "title": "510(k) Submission Support",
  "description": "Complete support for preparing and optimizing 510(k) submissions including predicate selection, substantial equivalence arguments, and special 510(k) strategies",
  "methodology": {
    "predicate_selection": [
      "1. Search 510(k) database for similar devices (last 5 years)",
      "2. Compare intended use statements for alignment",
      "3. Analyze technological characteristics",
      "4. Assess performance data requirements",
      "5. Create predicate comparison table",
      "6. Identify potential FDA concerns"
    ],
    "substantial_equivalence": [
      "1. Demonstrate same intended use",
      "2. Compare technological characteristics",
      "3. Address any differences with performance data",
      "4. Create SE argument flow chart",
      "5. Prepare FDA reviewer's decision tree"
    ],
    "submission_preparation": [
      "1. Complete eSTAR template sections",
      "2. Organize performance data by category",
      "3. Prepare device description with diagrams",
      "4. Draft substantial equivalence discussion",
      "5. Compile all required documentation",
      "6. Conduct internal FDA review simulation"
    ]
  },
  "required_knowledge": [
    "FDA's 510(k) Decision-Making Flowchart",
    "The New 510(k) Paradigm",
    "Refuse to Accept (RTA) Checklist",
    "Special vs Traditional vs Abbreviated 510(k)",
    "MDUFA V performance goals"
  ],
  "tools_required": [
    "FDA eSTAR platform",
    "510(k) Database",
    "Reliance Database for summaries",
    "FDA-recognized standards list"
  ],
  "output_format": {
    "predicate_comparison": "Detailed comparison table",
    "se_argument": "Substantial equivalence rationale",
    "submission_checklist": "Complete eSTAR checklist",
    "timeline": "Submission and review timeline",
    "response_strategy": "AI request response plan"
  },
  "quality_metrics": {
    "accuracy_target": "99%",
    "first_cycle_clearance": ">85%",
    "rta_acceptance": "100%"
  }
}
```

### CAP-FDA-003: De Novo Classification Guidance
```json
{
  "capability_id": "CAP-FDA-003",
  "title": "De Novo Classification Guidance",
  "description": "Strategic guidance for De Novo classification requests including risk analysis, special controls development, and post-market requirements",
  "methodology": {
    "eligibility_assessment": [
      "1. Confirm no valid predicate exists",
      "2. Verify device is not high risk (Class III)",
      "3. Assess if risks can be mitigated by special controls",
      "4. Review similar De Novo decisions",
      "5. Determine classification rationale"
    ],
    "special_controls_development": [
      "1. Identify all risks to health",
      "2. Develop mitigation measures for each risk",
      "3. Define performance standards",
      "4. Establish labeling requirements",
      "5. Specify post-market surveillance needs"
    ],
    "submission_strategy": [
      "1. Pre-Submission meeting preparation",
      "2. Clinical data requirements definition",
      "3. Classification request drafting",
      "4. Review timeline optimization",
      "5. Post-decision 510(k) pathway planning"
    ]
  },
  "required_knowledge": [
    "21 CFR Part 860 Subpart D",
    "De Novo guidance document",
    "Recent De Novo decisions database",
    "Risk-based classification principles"
  ],
  "quality_metrics": {
    "grant_rate_target": ">80%",
    "review_time": "<150 days"
  }
}
```

### CAP-FDA-004: PMA Development
```json
{
  "capability_id": "CAP-FDA-004",
  "title": "PMA Development",
  "description": "Comprehensive PMA application development including modular review strategies, clinical trial design, and panel preparation",
  "methodology": {
    "pma_strategy": [
      "1. Determine modular vs traditional PMA",
      "2. Design pivotal clinical trial",
      "3. Plan manufacturing information",
      "4. Develop preclinical testing strategy",
      "5. Prepare for advisory panel if required"
    ],
    "clinical_requirements": [
      "1. Define primary effectiveness endpoint",
      "2. Establish safety monitoring plan",
      "3. Calculate sample size with FDA input",
      "4. Design statistical analysis plan",
      "5. Plan post-approval studies"
    ]
  },
  "quality_metrics": {
    "approval_rate": ">75%",
    "review_timeline": "180-day target"
  }
}
```

### CAP-FDA-005: Pre-Submission Strategy
```json
{
  "capability_id": "CAP-FDA-005",
  "title": "Pre-Submission Strategy",
  "description": "Strategic planning and execution of FDA Pre-Submission (Q-Sub) meetings to gain regulatory clarity and agreement",
  "methodology": {
    "meeting_planning": [
      "1. Identify key regulatory questions",
      "2. Prioritize topics by criticality",
      "3. Prepare supporting documentation",
      "4. Anticipate FDA concerns",
      "5. Develop fallback positions"
    ],
    "document_preparation": [
      "1. Draft Pre-Sub cover letter",
      "2. Create device description section",
      "3. Formulate specific questions",
      "4. Compile preliminary data",
      "5. Prepare proposed regulatory strategy"
    ]
  },
  "quality_metrics": {
    "fda_agreement_rate": ">90%",
    "question_clarity_score": ">95%"
  }
}
```

---

## ðŸ”¬ CLINICAL TRIAL CAPABILITIES

### CAP-CT-001: Protocol Development
```json
{
  "capability_id": "CAP-CT-001",
  "title": "Clinical Protocol Development",
  "description": "Design comprehensive clinical investigation protocols that meet regulatory requirements and generate compelling evidence",
  "methodology": {
    "protocol_architecture": [
      "1. Define primary and secondary objectives",
      "2. Select appropriate study design",
      "3. Determine endpoints and success criteria",
      "4. Develop inclusion/exclusion criteria",
      "5. Create statistical analysis plan",
      "6. Design safety monitoring plan"
    ],
    "regulatory_alignment": [
      "1. Map to FDA IDE requirements",
      "2. Ensure ICH GCP compliance",
      "3. Address ISO 14155 elements",
      "4. Include GDPR/HIPAA protections",
      "5. Plan for international requirements"
    ],
    "operational_planning": [
      "1. Site selection criteria",
      "2. Recruitment strategy",
      "3. Data management plan",
      "4. Monitoring approach",
      "5. Timeline and budget"
    ]
  },
  "required_knowledge": [
    "ICH GCP E6(R2)",
    "ISO 14155:2020",
    "FDA IDE regulations",
    "Statistical principles (ICH E9)"
  ],
  "output_format": {
    "protocol_document": "50+ page comprehensive protocol",
    "synopsis": "2-page executive summary",
    "statistical_plan": "Detailed SAP",
    "operational_plan": "Site and recruitment strategy"
  },
  "quality_metrics": {
    "fda_acceptance": ">95%",
    "protocol_deviations": "<5%",
    "enrollment_success": ">90%"
  }
}
```

### CAP-CT-002: Statistical Planning
```json
{
  "capability_id": "CAP-CT-002",
  "title": "Statistical Planning",
  "description": "Advanced statistical design including sample size calculations, power analysis, and adaptive design strategies",
  "methodology": {
    "sample_size_determination": [
      "1. Define effect size and clinical relevance",
      "2. Set Type I and Type II error rates",
      "3. Account for dropout and loss to follow-up",
      "4. Consider multiple testing adjustments",
      "5. Plan for interim analyses"
    ],
    "statistical_methods": [
      "1. Select primary analysis method",
      "2. Define analysis populations",
      "3. Plan for missing data handling",
      "4. Design sensitivity analyses",
      "5. Specify subgroup analyses"
    ]
  },
  "required_knowledge": [
    "Biostatistical methods",
    "FDA statistical guidance",
    "Adaptive design principles",
    "Bayesian methods"
  ],
  "quality_metrics": {
    "power_achievement": ">80%",
    "statistical_validity": "100%"
  }
}
```

### CAP-CT-003: Endpoint Selection
```json
{
  "capability_id": "CAP-CT-003",
  "title": "Endpoint Selection",
  "description": "Strategic selection and validation of clinical endpoints that meet regulatory requirements and demonstrate clinical benefit",
  "methodology": {
    "endpoint_evaluation": [
      "1. Review regulatory precedent",
      "2. Assess clinical relevance",
      "3. Evaluate measurement reliability",
      "4. Consider patient perspectives",
      "5. Analyze feasibility"
    ],
    "validation_approach": [
      "1. Literature evidence review",
      "2. Expert consensus gathering",
      "3. Pilot testing if needed",
      "4. Statistical validation",
      "5. Regulatory feedback"
    ]
  },
  "quality_metrics": {
    "regulatory_acceptance": ">90%",
    "clinical_relevance_score": ">85%"
  }
}
```

---

## ðŸ”’ HIPAA COMPLIANCE CAPABILITIES

### CAP-HIPAA-001: Risk Assessment
```json
{
  "capability_id": "CAP-HIPAA-001",
  "title": "HIPAA Risk Assessment",
  "description": "Comprehensive security risk assessment per HIPAA Security Rule requirements",
  "methodology": {
    "risk_identification": [
      "1. Inventory all PHI touchpoints",
      "2. Identify threats and vulnerabilities",
      "3. Assess current security measures",
      "4. Determine likelihood and impact",
      "5. Calculate risk levels"
    ],
    "control_evaluation": [
      "1. Administrative safeguards review",
      "2. Physical safeguards assessment",
      "3. Technical safeguards analysis",
      "4. Organizational requirements check",
      "5. Policy and procedure evaluation"
    ],
    "remediation_planning": [
      "1. Prioritize risks by severity",
      "2. Develop mitigation strategies",
      "3. Create implementation timeline",
      "4. Estimate resource requirements",
      "5. Define success metrics"
    ]
  },
  "required_knowledge": [
    "45 CFR Parts 160, 162, 164",
    "NIST 800-66 guidance",
    "OCR audit protocols",
    "HHS Security Rule guidance"
  ],
  "output_format": {
    "risk_register": "Comprehensive risk inventory",
    "gap_analysis": "Control gaps identified",
    "remediation_plan": "Prioritized action items",
    "executive_summary": "Board-ready overview"
  },
  "quality_metrics": {
    "completeness": "100% PHI coverage",
    "accuracy": "100% regulatory alignment",
    "ocr_readiness": "Audit-ready documentation"
  }
}
```

### CAP-HIPAA-002: Security Implementation
```json
{
  "capability_id": "CAP-HIPAA-002",
  "title": "Security Implementation",
  "description": "Implementation of HIPAA Security Rule technical, physical, and administrative safeguards",
  "methodology": {
    "technical_safeguards": [
      "1. Access control implementation",
      "2. Audit log configuration",
      "3. Integrity controls setup",
      "4. Transmission security",
      "5. Encryption deployment"
    ],
    "administrative_safeguards": [
      "1. Security officer designation",
      "2. Workforce training program",
      "3. Access management procedures",
      "4. Security incident procedures",
      "5. Business associate management"
    ],
    "physical_safeguards": [
      "1. Facility access controls",
      "2. Workstation security",
      "3. Device and media controls",
      "4. Equipment disposal procedures",
      "5. Physical access monitoring"
    ]
  },
  "quality_metrics": {
    "implementation_completeness": "100%",
    "testing_validation": "All controls tested",
    "documentation_quality": "OCR audit ready"
  }
}
```

### CAP-HIPAA-003: Breach Response
```json
{
  "capability_id": "CAP-HIPAA-003",
  "title": "Breach Response Management",
  "description": "Complete breach response including assessment, notification, and remediation per HIPAA Breach Notification Rule",
  "methodology": {
    "breach_assessment": [
      "1. Discover and document incident",
      "2. Contain and secure PHI",
      "3. Assess scope and impact",
      "4. Perform risk assessment",
      "5. Determine notification requirements"
    ],
    "notification_process": [
      "1. Individual notifications (60 days)",
      "2. Media notifications (>500 individuals)",
      "3. HHS OCR notification",
      "4. Business associate notifications",
      "5. Documentation requirements"
    ],
    "remediation_actions": [
      "1. Root cause analysis",
      "2. Corrective action plan",
      "3. Preventive measures",
      "4. Workforce retraining",
      "5. Policy updates"
    ]
  },
  "quality_metrics": {
    "response_time": "<1 hour discovery",
    "notification_compliance": "100% on time",
    "recurrence_prevention": "Zero repeat incidents"
  }
}
```

---

## ðŸ’° REIMBURSEMENT CAPABILITIES

### CAP-REIMB-001: Code Mapping
```json
{
  "capability_id": "CAP-REIMB-001",
  "title": "Medical Code Mapping",
  "description": "Strategic mapping of medical devices to CPT, HCPCS, and ICD-10 codes for optimal reimbursement",
  "methodology": {
    "code_identification": [
      "1. Analyze device function and use",
      "2. Search existing CPT codes",
      "3. Review HCPCS Level II codes",
      "4. Identify applicable ICD-10 codes",
      "5. Assess new code need"
    ],
    "coverage_analysis": [
      "1. Review Medicare NCDs/LCDs",
      "2. Analyze commercial policies",
      "3. Identify coverage gaps",
      "4. Map to quality measures",
      "5. Assess prior authorization requirements"
    ],
    "strategy_development": [
      "1. Determine optimal coding path",
      "2. Calculate reimbursement rates",
      "3. Plan provider education",
      "4. Create billing guides",
      "5. Design appeal templates"
    ]
  },
  "required_knowledge": [
    "CPT coding guidelines",
    "HCPCS Level II codes",
    "ICD-10-CM/PCS",
    "Medicare coverage policies",
    "Commercial payer policies"
  ],
  "output_format": {
    "coding_strategy": "Recommended codes with rationale",
    "coverage_map": "Payer-by-payer analysis",
    "billing_guide": "Provider instructions",
    "financial_impact": "Revenue projections"
  },
  "quality_metrics": {
    "coding_accuracy": ">95%",
    "claim_acceptance": ">90%",
    "appeal_success": ">75%"
  }
}
```

### CAP-REIMB-002: Coverage Strategy
```json
{
  "capability_id": "CAP-REIMB-002",
  "title": "Coverage Strategy Development",
  "description": "Development of comprehensive coverage strategies across Medicare, Medicaid, and commercial payers",
  "methodology": {
    "medicare_strategy": [
      "1. NCD/LCD analysis",
      "2. Benefit category determination",
      "3. NTAP/TPT eligibility",
      "4. Quality measure alignment",
      "5. MAC engagement plan"
    ],
    "commercial_strategy": [
      "1. Payer policy analysis",
      "2. Medical policy development",
      "3. Value proposition creation",
      "4. Pilot program design",
      "5. Contract negotiation prep"
    ]
  },
  "quality_metrics": {
    "coverage_achievement": ">70% lives",
    "time_to_coverage": "<12 months"
  }
}
```

### CAP-REIMB-003: Economic Modeling
```json
{
  "capability_id": "CAP-REIMB-003",
  "title": "Health Economic Modeling",
  "description": "Development of economic models including cost-effectiveness analysis, budget impact models, and value demonstrations",
  "methodology": {
    "cost_effectiveness": [
      "1. Define comparators",
      "2. Model clinical outcomes",
      "3. Calculate costs",
      "4. Compute ICERs",
      "5. Sensitivity analysis"
    ],
    "budget_impact": [
      "1. Define population",
      "2. Estimate uptake",
      "3. Calculate costs",
      "4. Project savings",
      "5. Break-even analysis"
    ]
  },
  "quality_metrics": {
    "model_validity": "Peer review standard",
    "icer_threshold": "<$100K/QALY"
  }
}
```

---

## âœ… QUALITY MANAGEMENT CAPABILITIES

### CAP-QMS-001: QMS Design
```json
{
  "capability_id": "CAP-QMS-001",
  "title": "Quality Management System Design",
  "description": "Design and implementation of ISO 13485 and FDA QMSR compliant quality management systems",
  "methodology": {
    "qms_architecture": [
      "1. Define quality policy and objectives",
      "2. Map process interactions",
      "3. Establish document hierarchy",
      "4. Design control mechanisms",
      "5. Create metrics framework"
    ],
    "process_development": [
      "1. Management responsibility",
      "2. Resource management",
      "3. Product realization",
      "4. Measurement and analysis",
      "5. Improvement processes"
    ],
    "implementation_planning": [
      "1. Gap assessment",
      "2. Process documentation",
      "3. Training development",
      "4. Pilot implementation",
      "5. Full deployment"
    ]
  },
  "required_knowledge": [
    "ISO 13485:2016",
    "FDA 21 CFR Part 820",
    "FDA QMSR (2024)",
    "MDSAP requirements",
    "ICH Q10 principles"
  ],
  "quality_metrics": {
    "audit_findings": "Zero critical",
    "process_efficiency": "Top quartile",
    "certification_achievement": "100% pass rate"
  }
}
```

### CAP-QMS-002: Design Controls
```json
{
  "capability_id": "CAP-QMS-002",
  "title": "Design Control Implementation",
  "description": "Implementation of design controls for medical device development per FDA and ISO requirements",
  "methodology": {
    "design_planning": [
      "1. Create design and development plan",
      "2. Define design stages and reviews",
      "3. Assign responsibilities",
      "4. Identify resource needs",
      "5. Set quality objectives"
    ],
    "design_process": [
      "1. User needs capture",
      "2. Design inputs definition",
      "3. Design outputs creation",
      "4. Design verification",
      "5. Design validation",
      "6. Design transfer",
      "7. Design changes"
    ],
    "documentation": [
      "1. Design History File",
      "2. Design reviews",
      "3. V&V protocols and reports",
      "4. Risk management file",
      "5. Traceability matrix"
    ]
  },
  "quality_metrics": {
    "design_review_effectiveness": ">95%",
    "first_pass_success": ">90%",
    "change_control_compliance": "100%"
  }
}
```

### CAP-QMS-003: Risk Management
```json
{
  "capability_id": "CAP-QMS-003",
  "title": "Risk Management System",
  "description": "Implementation of risk management per ISO 14971 for medical devices",
  "methodology": {
    "risk_analysis": [
      "1. Hazard identification",
      "2. Risk estimation",
      "3. Risk evaluation",
      "4. Risk control",
      "5. Residual risk assessment"
    ],
    "risk_control": [
      "1. Inherent safety",
      "2. Protective measures",
      "3. Information for safety",
      "4. Risk-benefit analysis",
      "5. Overall residual risk"
    ]
  },
  "quality_metrics": {
    "risk_coverage": "100% identified hazards",
    "control_effectiveness": ">90%",
    "review_frequency": "Annual minimum"
  }
}
```

---

## ðŸŽ¨ MEDICAL WRITING CAPABILITIES

### CAP-MW-001: Regulatory Writing
```json
{
  "capability_id": "CAP-MW-001",
  "title": "Regulatory Document Writing",
  "description": "Creation of regulatory submissions, responses, and supporting documentation",
  "methodology": {
    "document_planning": [
      "1. Define document purpose and audience",
      "2. Gather source materials",
      "3. Create document outline",
      "4. Establish review timeline",
      "5. Identify reviewers"
    ],
    "content_development": [
      "1. Executive summary creation",
      "2. Technical sections drafting",
      "3. Data presentation",
      "4. Risk-benefit discussion",
      "5. Conclusions and claims"
    ],
    "quality_assurance": [
      "1. Technical accuracy review",
      "2. Regulatory compliance check",
      "3. Editorial review",
      "4. Formatting validation",
      "5. Final quality check"
    ]
  },
  "quality_metrics": {
    "first_draft_quality": ">90%",
    "regulatory_acceptance": ">95%",
    "revision_cycles": "<3"
  }
}
```

### CAP-MW-002: Clinical Documentation
```json
{
  "capability_id": "CAP-MW-002",
  "title": "Clinical Documentation",
  "description": "Creation of clinical study protocols, reports, and related documentation",
  "methodology": {
    "protocol_writing": [
      "1. Background and rationale",
      "2. Objectives and endpoints",
      "3. Study design",
      "4. Statistical considerations",
      "5. Administrative aspects"
    ],
    "report_writing": [
      "1. Synopsis development",
      "2. Results presentation",
      "3. Statistical analysis",
      "4. Safety reporting",
      "5. Conclusions"
    ]
  },
  "quality_metrics": {
    "ich_compliance": "100%",
    "clarity_score": ">90%",
    "review_time": "<2 weeks"
  }
}
```

---

## ðŸ“Š CLINICAL EVIDENCE CAPABILITIES

### CAP-CEA-001: Systematic Review
```json
{
  "capability_id": "CAP-CEA-001",
  "title": "Systematic Literature Review",
  "description": "Conduct systematic reviews per PRISMA guidelines for medical device evidence",
  "methodology": {
    "search_strategy": [
      "1. Define PICO questions",
      "2. Select databases",
      "3. Develop search strings",
      "4. Execute searches",
      "5. Document process"
    ],
    "study_selection": [
      "1. Title/abstract screening",
      "2. Full-text review",
      "3. Quality assessment",
      "4. Data extraction",
      "5. Evidence synthesis"
    ]
  },
  "quality_metrics": {
    "prisma_compliance": "100%",
    "search_sensitivity": ">95%",
    "inter-rater_agreement": ">0.8 kappa"
  }
}
```

### CAP-CEA-002: Meta-Analysis
```json
{
  "capability_id": "CAP-CEA-002",
  "title": "Meta-Analysis",
  "description": "Perform meta-analyses and quantitative evidence synthesis",
  "methodology": {
    "statistical_analysis": [
      "1. Effect size calculation",
      "2. Heterogeneity assessment",
      "3. Fixed/random effects modeling",
      "4. Subgroup analysis",
      "5. Publication bias assessment"
    ],
    "quality_assessment": [
      "1. Risk of bias evaluation",
      "2. GRADE assessment",
      "3. Certainty of evidence",
      "4. Sensitivity analysis",
      "5. Robustness checks"
    ]
  },
  "quality_metrics": {
    "statistical_validity": "100%",
    "transparency": "Full reproducibility",
    "grade_quality": "Moderate or higher"
  }
}
```

---

## ðŸ¤– AI/ML CAPABILITIES

### CAP-AI-001: Algorithm Validation
```json
{
  "capability_id": "CAP-AI-001",
  "title": "AI/ML Algorithm Validation",
  "description": "Comprehensive validation of AI/ML algorithms for healthcare applications",
  "methodology": {
    "analytical_validation": [
      "1. Standalone performance testing",
      "2. Robustness assessment",
      "3. Failure mode analysis",
      "4. Bias evaluation",
      "5. Generalization testing"
    ],
    "clinical_validation": [
      "1. Clinical study design",
      "2. Ground truth establishment",
      "3. Performance metrics",
      "4. Subgroup analysis",
      "5. Clinical significance"
    ],
    "continuous_learning": [
      "1. Drift detection",
      "2. Performance monitoring",
      "3. Update protocols",
      "4. Version control",
      "5. Retraining triggers"
    ]
  },
  "required_knowledge": [
    "FDA AI/ML guidance",
    "Good Machine Learning Practice",
    "ISO/IEC 23894",
    "Statistical validation methods"
  ],
  "quality_metrics": {
    "algorithm_accuracy": ">95%",
    "bias_detection": "All subgroups tested",
    "fda_compliance": "100%"
  }
}
```

### CAP-AI-002: Explainability Implementation
```json
{
  "capability_id": "CAP-AI-002",
  "title": "AI Explainability Implementation",
  "description": "Implementation of explainable AI techniques for healthcare algorithms",
  "methodology": {
    "explainability_methods": [
      "1. Feature importance analysis",
      "2. SHAP/LIME implementation",
      "3. Attention visualization",
      "4. Decision tree approximation",
      "5. Counterfactual explanations"
    ],
    "clinical_integration": [
      "1. Clinician-friendly visualizations",
      "2. Uncertainty quantification",
      "3. Confidence indicators",
      "4. Evidence mapping",
      "5. Decision support design"
    ]
  },
  "quality_metrics": {
    "interpretability_score": ">85%",
    "clinician_satisfaction": ">90%",
    "decision_transparency": "Full traceability"
  }
}
```

---

## ðŸ“‹ Capability Management

### Version Control
```json
{
  "capability_version": "1.0.0",
  "last_updated": "2025-01-17",
  "update_log": [
    {
      "version": "1.0.0",
      "date": "2025-01-17",
      "changes": "Initial capability library creation",
      "author": "System"
    }
  ]
}
```

### Capability Dependencies
```json
{
  "dependencies": {
    "CAP-FDA-002": ["CAP-FDA-001"],
    "CAP-FDA-003": ["CAP-FDA-001"],
    "CAP-CT-002": ["CAP-CT-001"],
    "CAP-REIMB-002": ["CAP-REIMB-001"],
    "CAP-QMS-002": ["CAP-QMS-001"]
  }
}
```

### Usage Tracking
```json
{
  "usage_metrics": {
    "track_frequency": "Log each capability call",
    "track_success_rate": "Monitor completion rates",
    "track_time": "Measure execution time",
    "track_user_feedback": "Collect satisfaction scores"
  }
}
```

---

## ðŸš¦ Capability Loading Protocol

### Loading Process
```python
def load_capability(capability_id):
    """
    Load a specific capability from the library
    
    Args:
        capability_id (str): Unique capability identifier
    
    Returns:
        dict: Complete capability definition
    """
    capability = fetch_from_library(capability_id)
    validate_capability(capability)
    check_dependencies(capability)
    return capability
```

### Capability Execution
```python
def execute_capability(agent, capability_id, parameters):
    """
    Execute a capability with given parameters
    
    Args:
        agent: The agent instance
        capability_id (str): Capability to execute
        parameters (dict): Input parameters
    
    Returns:
        dict: Capability execution results
    """
    capability = load_capability(capability_id)
    validate_parameters(parameters, capability)
    results = agent.run_capability(capability, parameters)
    log_execution(capability_id, results)
    return results
```

---

## ðŸ“Š Capability Performance Monitoring

### Key Metrics
```json
{
  "performance_monitoring": {
    "accuracy": {
      "target": ">95%",
      "measurement": "Compare outputs to ground truth",
      "frequency": "Weekly"
    },
    "execution_time": {
      "target": "<5 minutes",
      "measurement": "End-to-end timing",
      "frequency": "Per execution"
    },
    "user_satisfaction": {
      "target": ">4.5/5",
      "measurement": "User feedback surveys",
      "frequency": "Monthly"
    },
    "error_rate": {
      "target": "<2%",
      "measurement": "Failed executions / total",
      "frequency": "Daily"
    }
  }
}
```

---

*Document 2 Version: 1.0*
*Last Updated: January 17, 2025*
*Next Review: February 17, 2025*